Report Detail
Global Cephalosporin Market Insights, Forecast to 2025
- RnM3059890 |
- 02 April, 2019 |
- Global |
- 123 Pages |
- QYResearch |
- Pharma & Healthcare
Cephalosporin is an antibiotic medication commonly prescribed to treat several different types of infections.
The classification of Cephalosporin includes First Generation, Second Generation, Third Generation, Fourth Generation and the proportion of Third Generation in 2016 is about 37.2%, and the proportion is in increasing trend from 2012 to 2016.
China is the largest supplier of Cephalosporin, with a production market share nearly 43% in 2016. India is the second largest supplier of Cephalosporin, enjoying production market share nearly 22.3% in 2016.
Market competition is intense. Union Chempharma, NCPC, Qilu Antibiotics, Lupin Pharmaceuticals, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The global Cephalosporin market is valued at 3690 million US$ in 2018 and will reach 4280 million US$ by the end of 2025, growing at a CAGR of 1.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Cephalosporin market based on company, product type, end user and key regions.
This report studies the global market size of Cephalosporin in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cephalosporin in these regions.
This research report categorizes the global Cephalosporin market by top players/brands, region, type and end user. This report also studies the global Cephalosporin market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Union Chempharma
NCPC
Qilu Antibiotics
Lupin Pharmaceuticals
Hospira
Dhanuka Laboratories
Fukang
Dongying Pharmaceutical
Alkem
SALUBRIS
LIVZON
Hetero Drugs
CSPC
TEVA
Orchid Pharma
Taj Pharmaceuticals
Covalent Laboratories
United Laboratories
Aurobindo
Wockhardt
LKPC
HPGC
Huafangpharm
Market size by Product
First Generation
Second Generation
Third Generation
Fourth Generation
Market size by End User
Oral
Injection
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Cephalosporin market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Cephalosporin market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Cephalosporin companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Cephalosporin submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Cephalosporin are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Cephalosporin market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Cephalosporin Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Cephalosporin Market Size Growth Rate by Product
- 1.4.2 First Generation
- 1.4.3 Second Generation
- 1.4.4 Third Generation
- 1.4.5 Fourth Generation
- 1.5 Market by End User
- 1.5.1 Global Cephalosporin Market Size Growth Rate by End User
- 1.5.2 Oral
- 1.5.3 Injection
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Cephalosporin Market Size
- 2.1.1 Global Cephalosporin Revenue 2014-2025
- 2.1.2 Global Cephalosporin Sales 2014-2025
- 2.2 Cephalosporin Growth Rate by Regions
- 2.2.1 Global Cephalosporin Sales by Regions
- 2.2.2 Global Cephalosporin Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Cephalosporin Sales by Manufacturers
- 3.1.1 Cephalosporin Sales by Manufacturers
- 3.1.2 Cephalosporin Sales Market Share by Manufacturers
- 3.1.3 Global Cephalosporin Market Concentration Ratio (CR5 and HHI)
- 3.2 Cephalosporin Revenue by Manufacturers
- 3.2.1 Cephalosporin Revenue by Manufacturers (2014-2019)
- 3.2.2 Cephalosporin Revenue Share by Manufacturers (2014-2019)
- 3.3 Cephalosporin Price by Manufacturers
- 3.4 Cephalosporin Manufacturing Base Distribution, Product Types
- 3.4.1 Cephalosporin Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Cephalosporin Product Type
- 3.4.3 Date of International Manufacturers Enter into Cephalosporin Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Cephalosporin Sales by Product
- 4.2 Global Cephalosporin Revenue by Product
- 4.3 Cephalosporin Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Cephalosporin Breakdown Data by End User
6 North America
- 6.1 North America Cephalosporin by Countries
- 6.1.1 North America Cephalosporin Sales by Countries
- 6.1.2 North America Cephalosporin Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Cephalosporin by Product
- 6.3 North America Cephalosporin by End User
7 Europe
- 7.1 Europe Cephalosporin by Countries
- 7.1.1 Europe Cephalosporin Sales by Countries
- 7.1.2 Europe Cephalosporin Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Cephalosporin by Product
- 7.3 Europe Cephalosporin by End User
8 Asia Pacific
- 8.1 Asia Pacific Cephalosporin by Countries
- 8.1.1 Asia Pacific Cephalosporin Sales by Countries
- 8.1.2 Asia Pacific Cephalosporin Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Cephalosporin by Product
- 8.3 Asia Pacific Cephalosporin by End User
9 Central & South America
- 9.1 Central & South America Cephalosporin by Countries
- 9.1.1 Central & South America Cephalosporin Sales by Countries
- 9.1.2 Central & South America Cephalosporin Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Cephalosporin by Product
- 9.3 Central & South America Cephalosporin by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Cephalosporin by Countries
- 10.1.1 Middle East and Africa Cephalosporin Sales by Countries
- 10.1.2 Middle East and Africa Cephalosporin Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Cephalosporin by Product
- 10.3 Middle East and Africa Cephalosporin by End User
11 Company Profiles
- 11.1 Union Chempharma
- 11.1.1 Union Chempharma Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Union Chempharma Cephalosporin Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Union Chempharma Cephalosporin Products Offered
- 11.1.5 Union Chempharma Recent Development
- 11.2 NCPC
- 11.2.1 NCPC Company Details
- 11.2.2 Company Business Overview
- 11.2.3 NCPC Cephalosporin Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 NCPC Cephalosporin Products Offered
- 11.2.5 NCPC Recent Development
- 11.3 Qilu Antibiotics
- 11.3.1 Qilu Antibiotics Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Qilu Antibiotics Cephalosporin Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Qilu Antibiotics Cephalosporin Products Offered
- 11.3.5 Qilu Antibiotics Recent Development
- 11.4 Lupin Pharmaceuticals
- 11.4.1 Lupin Pharmaceuticals Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Lupin Pharmaceuticals Cephalosporin Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Lupin Pharmaceuticals Cephalosporin Products Offered
- 11.4.5 Lupin Pharmaceuticals Recent Development
- 11.5 Hospira
- 11.5.1 Hospira Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Hospira Cephalosporin Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Hospira Cephalosporin Products Offered
- 11.5.5 Hospira Recent Development
- 11.6 Dhanuka Laboratories
- 11.6.1 Dhanuka Laboratories Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Dhanuka Laboratories Cephalosporin Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Dhanuka Laboratories Cephalosporin Products Offered
- 11.6.5 Dhanuka Laboratories Recent Development
- 11.7 Fukang
- 11.7.1 Fukang Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Fukang Cephalosporin Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Fukang Cephalosporin Products Offered
- 11.7.5 Fukang Recent Development
- 11.8 Dongying Pharmaceutical
- 11.8.1 Dongying Pharmaceutical Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Dongying Pharmaceutical Cephalosporin Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Dongying Pharmaceutical Cephalosporin Products Offered
- 11.8.5 Dongying Pharmaceutical Recent Development
- 11.9 Alkem
- 11.9.1 Alkem Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Alkem Cephalosporin Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Alkem Cephalosporin Products Offered
- 11.9.5 Alkem Recent Development
- 11.10 SALUBRIS
- 11.10.1 SALUBRIS Company Details
- 11.10.2 Company Business Overview
- 11.10.3 SALUBRIS Cephalosporin Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 SALUBRIS Cephalosporin Products Offered
- 11.10.5 SALUBRIS Recent Development
- 11.11 LIVZON
- 11.12 Hetero Drugs
- 11.13 CSPC
- 11.14 TEVA
- 11.15 Orchid Pharma
- 11.16 Taj Pharmaceuticals
- 11.17 Covalent Laboratories
- 11.18 United Laboratories
- 11.19 Aurobindo
- 11.20 Wockhardt
- 11.21 LKPC
- 11.22 HPGC
- 11.23 Huafangpharm
12 Future Forecast
- 12.1 Cephalosporin Market Forecast by Regions
- 12.1.1 Global Cephalosporin Sales Forecast by Regions 2019-2025
- 12.1.2 Global Cephalosporin Revenue Forecast by Regions 2019-2025
- 12.2 Cephalosporin Market Forecast by Product
- 12.2.1 Global Cephalosporin Sales Forecast by Product 2019-2025
- 12.2.2 Global Cephalosporin Revenue Forecast by Product 2019-2025
- 12.3 Cephalosporin Market Forecast by End User
- 12.4 North America Cephalosporin Forecast
- 12.5 Europe Cephalosporin Forecast
- 12.6 Asia Pacific Cephalosporin Forecast
- 12.7 Central & South America Cephalosporin Forecast
- 12.8 Middle East and Africa Cephalosporin Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Cephalosporin Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Cephalosporin . Industry analysis & Market Report on Cephalosporin is a syndicated market report, published as Global Cephalosporin Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Cephalosporin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
